A Phase 1, Open Label Study In Healthy Subjects To Estimate The Effect Of Food And The Drug-Drug Interaction Potential Of Ketoconazole On PF-04449913 Pharmacokinetics
Phase of Trial: Phase I
Latest Information Update: 01 Aug 2014
Price : $35 *
At a glance
- Drugs Glasdegib (Primary) ; Ketoconazole
- Indications Acute myeloid leukaemia; Chronic myeloid leukaemia; Haematological malignancies; Myelodysplastic syndromes; Solid tumours
- Focus Pharmacokinetics
- Sponsors Pfizer
- 10 Dec 2013 Results presented at the 55th Annual Meeting and Exposition of the American Society of Hematology.
- 25 Feb 2013 Actual initiation date (Dec 2012) added as reported by ClinicalTrials.gov.
- 01 Feb 2013 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History